Abound Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Abound Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$285	Hold	1	–	–	﹤0.01%	1045
2026 Q1	$297	Hold	1	–	–	﹤0.01%	1132
2025 Q4	$304	Hold	1	–	–	﹤0.01%	1042
2025 Q3	$341	Hold	1	–	–	﹤0.01%	985
2025 Q2	$243	Hold	1	–	–	﹤0.01%	975
2025 Q1	$273	Hold	1	–	–	﹤0.01%	894
2024 Q4	$185	Hold	1	–	–	﹤0.01%	1102
2024 Q3	$225	Hold	1	–	–	﹤0.01%	1096
2024 Q2	$143	Hold	1	–	–	﹤0.01%	1147
2024 Q1	$157	Hold	1	–	–	﹤0.01%	1255
2023 Q4	$181	Hold	1	–	–	﹤0.01%	1272
2023 Q3	$180	Hold	1	–	–	﹤0.01%	1120
2023 Q2	$179	Buy	+1	New	+$230	﹤0.01%	1162

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Abound Wealth Management's ONC Position: Q2 2026 in Review

Abound Wealth Management held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 1 share worth $285. The position accounts for ﹤0.01% of the portfolio, ranked #1045.

Abound Wealth Management first reported a position in ONC in Q2 2023 and has held it in 13 quarters since. The position peaked at $341 in Q3 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Abound Wealth Management held 1 share of BeOne Medicines Ltd worth $285 as of Q2 2026.
Abound Wealth Management left its BeOne Medicines Ltd share count unchanged in Q2 2026.
BeOne Medicines Ltd made up ﹤0.01% of Abound Wealth Management's portfolio in Q2 2026, its #1045 holding.
Abound Wealth Management first reported a position in BeOne Medicines Ltd in Q2 2023 and has held it in 13 quarters since.
Abound Wealth Management's BeOne Medicines Ltd position peaked at $341 in Q3 2025.
282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Abound Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.